Xarelto MDL Lawsuits Are Different From Class Actions

October 01, 2015 – – BloodThinnerHelp.com reports today on the difference between the current Xarelto litigation and class action lawsuits. Although sometimes confused or used interchangeably, multidistrict litigation and class action lawsuits are very different. A large number of the current cases filed against the manufacturers of Xarelto, more than 1,200, are consolidated into a federal multidistrict litigation in the United States District Court for the Eastern District of Louisiana. Consolidating cases into an MDL still allows these cases to be tried separately and settlements to be decided individually. This is especially important because the circumstances of the cases filed and the injuries the plaintiffs suffered all greatly vary. For more detailed information on the Xarelto lawsuits, click here.

In a class action lawsuit, all of the cases filed are consolidated into one large case and the result will be the same for everyone involved, making it very inappropriate for the current Xarelto litigation. Currently, there is no class action lawsuit filed against the manufacturers of Xarelto in regards to the drug’s defects.

Xarelto Lawsuits Filed in an MDL:

An MDL is a legal management system that streamlines the judicial process for all parties involved. In December 2014 a motion was filed to consolidate all of the federally filed Xarelto lawsuits into an MDL. Lawsuits can be filed into an MDL if they all make similar allegations against the same defendant. An MDL enables thousands of cases to move quickly through the legal system, saves on judicial resources, and speeds up the process for both sides. In addition to the Xarelto MDL, there are about 400 cases filed in a mass tort group in Philadelphia, a similar legal management system.

Xarelto Lawsuits Make Similar Allegations:

The Xarelto lawsuits are able to be consolidated because they make similar allegations against the drug, including that the drug causes severe internal bleeding which can lead to serious injury and death. The lawsuits also allege that the manufacturers of Xarelto, Bayer AG and Johnson&Johnson, were aware of the dangers of the drug yet released it onto the market anyway.

The lawsuits allege that Xarelto is a more dangerous drug than traditional blood thinners because Xarelto does not have a corresponding antidote. If a patient experiences an internal bleeding injury and is taking a traditional blood thinner such as Warfarin, a doctor will be able to administer Vitamin K and the patient’s blood will clot again. If a ptient is taking Xarelto and suffers an internal bleed, there is no drug available to reverse Xarelto’s anticoagulant effects and make their blood clot.

“We strongly encourage anyone who believes they have been harmed by Xarelto to contact us immediately.” Marc Goldich, Xarelto attorney, said. “We expect to see more cases filed as the litigation progresses.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004506